Format

Send to

Choose Destination
Oncogene. 2015 Aug 20;34(34):4448-59. doi: 10.1038/onc.2014.372. Epub 2014 Nov 24.

A stress-induced early innate response causes multidrug tolerance in melanoma.

Author information

1
Cancer Biology Unit, Department of Dermatology, Medical University of Graz, Graz, Austria.
2
Center for Medical Research, Medical University of Graz, Graz, Austria.
3
Dermatology Research Centre, Translational Research Institute, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
4
Institute of Pathology, Medical University of Graz, Graz, Austria.
5
The Wistar Institute, Philadelphia, PA, USA.
6
The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.

Abstract

Acquired drug resistance constitutes a major challenge for effective cancer therapies with melanoma being no exception. The dynamics leading to permanent resistance are poorly understood but are important to design better treatments. Here we show that drug exposure, hypoxia or nutrient starvation leads to an early innate cell response in melanoma cells resulting in multidrug resistance, termed induced drug-tolerant cells (IDTCs). Transition into the IDTC state seems to be an inherent stress reaction for survival toward unfavorable environmental conditions or drug exposure. The response comprises chromatin remodeling, activation of signaling cascades and markers implicated in cancer stemness with higher angiogenic potential and tumorigenicity. These changes are characterized by a common increase in CD271 expression concomitantly with loss of differentiation markers such as melan-A and tyrosinase, enhanced aldehyde dehydrogenase (ALDH) activity and upregulation of histone demethylases. Accordingly, IDTCs show a loss of H3K4me3, H3K27me3 and gain of H3K9me3 suggesting activation and repression of differential genes. Drug holidays at the IDTC state allow for reversion into parental cells re-sensitizing them to the drug they were primarily exposed to. However, upon continuous drug exposure IDTCs eventually transform into permanent and irreversible drug-resistant cells. Knockdown of CD271 or KDM5B decreases transition into the IDTC state substantially but does not prevent it. Targeting IDTCs would be crucial for sustainable disease management and prevention of acquired drug resistance.

PMID:
25417704
PMCID:
PMC4442085
DOI:
10.1038/onc.2014.372
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center